HOLX stock on watch after B share buyback program (NASDAQ:HOLX)
Melpomenem Hologic, Inc. (NASDAQ:HOLX), a Marlborough, Massachusetts-based maker of diagnostic products, has announced a stock repurchase program t...
Melpomenem Hologic, Inc. (NASDAQ:HOLX), a Marlborough, Massachusetts-based maker of diagnostic products, has announced a stock repurchase program to buy up to $1B worth of the company's outstanding common stock over five years. The program took effect as of the market close on Sep. 23 following the authorization from the company's board of directors on the previous day, HOLX said in a regulatory filing. The new buyback program replaces the company's previous $1B repurchase program, which had about $150M remaining as of Sep.